Protagonist Therapeutics Announces U.S. FDA Approval of ICOTYDE(TM) (icotrokinra) for the Treatment of Moderate to Severe Plaque Psoriasis

March 18, 2026 8:05 AM

Protagonist Therapeutics, Inc. (NASDAQ:PTGX) ("Protagonist" or "the Company") announced today that Johnson & Johnson received U.S. Food and Drug Administration (FDA) approval for ICOTYDE™ (icotrokinra), an interleukin-23 (IL-23) receptor antagonist for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients 12 years of age and older who weigh at least 40 kg who are candidates for systemic therapy or phototherapy....

Read more

IKS Health Earns Top Client-Rated Honors in Three 2026 Black Book Research Reports

March 18, 2026 8:00 AM

Black Book today announced that IKS Health has achieved top client-rated recognition across three newly released 2026 market evaluations: AI-Driven RCM Managed Services, Managed Medical Coding Services, and Clinical Documentation & AI Services.The 2026 Black Book findings place IKS Health at the top of key performance-based client evaluations in three operational categories that healthcare organizations increasingly consider interdependent:...

Read more

Medicus Pharma To Discuss Positive Skinject(R) Phase 2 Topline Results In Fireside Chat Hosted By Brookline Capital Markets Biotechnology Equity Research Analyst

March 18, 2026 7:30 AM

Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics assets, announced today that members of its executive management team, led by Dr. Raza Bokhari, Executive Chairman & CEO, will participate in a live fireside chat on Thursday, March 19, 2026, hosted by Kumaraguru (Kumar) Raja, Ph.D., Senior...

Read more

Zomedica Announces Strategic Collaboration with Boehringer Ingelheim to Expand Equine Endocrine Diagnostic Testing Using TRUFORMA(R) Platform

March 18, 2026 6:00 AM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic solutions for equine and companion animals, today announced a collaboration with Boehringer Ingelheim Animal Health USA Inc., a global leader in the animal health industry, to enhance early detection along with treatment and monitoring of pituitary pars intermedia dysfunction (PPID) in horses.The collaboration integrates...

Read more

Technology is Transforming Medical Courier Services as Healthcare Logistics Adopts Digital Systems

March 18, 2026 5:10 AM

Medical courier services are undergoing a significant shift as healthcare organizations adopt technology-driven logistics systems designed to improve the transportation of laboratory specimens, pharmaceuticals, and medical supplies.Across the healthcare sector, courier operations are increasingly moving away from traditional phone-based dispatch and paper documentation toward digital platforms that provide real-time tracking, temperature...

Read more

New Preclinical Data on Anti-Tumor Effects of Nadunolimab in Metastatic Colorectal Cancer Presented at the Keystone Cancer Immunotherapy Conference

March 18, 2026 2:45 AM

Cantargia (STO:CANTA) today reported the presentation of new pre-clinical data highlighting how a murine surrogate antibody to nadunolimab, an anti-IL1RAP antibody currently in clinical development, may inhibit immunosuppression in metastatic colorectal cancer (CRC), an effect especially pronounced in combination with an immune-checkpoint inhibitor. The data were generated by Dr Merad's research group at Icahn School of Medicine at Mount Sinai...

Read more

Psyence Group Inc. Provides Update on Proposed Amalgamation with GoldCoast Resource Corp.

March 17, 2026 7:00 PM

Psyence Group Inc. (CSE:PSYG) ("Psyence" or the "Company") announces that GoldCoast Resource Corp. ("GoldCoast"), the private company with which Psyence has entered into a definitive amalgamation agreement dated November 21, 2025, as amended February 24, 2026 (collectively, the "Amalgamation Agreement"), has completed a brokered private placement through the issuance of 6,853,840 common shares of GoldCoast (each, a "GoldCoast Share") at a price...

Read more

Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2026

March 17, 2026 5:05 PM

Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, today announced that revenues for the quarter ended January 31, 2026 were approximately $2.3 million, a decrease of approximately $0.2 million when compared to...

Read more

C2 Vitamin Wins Prestigious Asia-Level Honour at Korea Influencer & Business Awards 2025

March 17, 2026 1:05 PM

C2 Vitamin, the premium health and wellness brand under C DRINK CO., LTD., has been honoured with "The Global Dietary Supplements Impact Award" at the Korea Influencer & Business Awards 2025 (KIB Awards 2025), held at the JW Marriott Hotel, Seoul. The recognition marks a significant milestone for the brand and highlights its growing influence in the Asian health and wellness sector.Led by Ms. Thanyarat Jirathitikeat, Chief Executive Officer of...

Read more

Burnout and Chronic Stress Surge Across U.S. Workforce - Shifa Health Responds with New Precision Wellness Clinic on Its 23rd Anniversary

March 17, 2026 12:00 PM

Burnout and chronic stress are rapidly becoming major threats to workforce health and productivity in the United States. A Gallup workplace study reports that 76% of employees experience burnout at least sometimes, while nearly one in four say they feel burned out very often or always.Behind these statistics are professionals who wake up exhausted, struggle to focus, and feel like they are running on empty despite working harder than ever.In...

Read more

UK Fertility Care Shifts Toward At-Home Diagnostics as Sapyen and Avenues Launch a Couple-First Testing Model

March 17, 2026 11:15 AM

A structural change is taking place at the front door of UK fertility care. For the first time, a leading fertility clinic has redesigned how treatment begins so that both partners in a couple complete clinical fertility screening at home, before attending a first consultation. Avenues Clinic has partnered exclusively with Sapyen to embed at-home semen analysis for men and at-home Anti-Müllerian Hormone (AMH) testing for women directly into its...

Read more

Innovations in Therapy: Updates to Billable Services

March 17, 2026 9:00 AM

A significant portion of a physical, occupational, or speech therapist's role involves caregiver education and patient training. This instruction is essential to ensure patients perform activities of daily living safely and correctly, yet it has historically been difficult to prioritize amid already demanding caseloads; particularly when the time spent was not considered billable.Recent updates to the CMS Final Rule have changed that. Under...

Read more

PillSafe Secures Primary Investment in Seed Round for its Wirelessly Connected Adherence System

March 17, 2026 9:00 AM

PillSafe®, developer of patented smart medication delivery technology that satisfies insurers' Remote Therapeutic Monitoring requirements, announces the primary investment in its current SAFE seed-round opportunity. The investment marks an early and significant milestone in the company's plan to bring its Wirelessly Connected Adherence System to market. Doctor's Orders Infusion Services, LLC is the first investor in the current investment...

Read more

Ankle & Foot Centers Shares the Importance of Diabetic Foot Care

March 17, 2026 9:00 AM

Ankle & Foot Centers of America is highlighting the importance of routine foot care for individuals living with diabetes and encouraging patients to seek early evaluation of potential foot problems.Diabetes can impact both circulation and nerve function in the feet. Reduced blood flow can slow the body's ability to heal, while nerve damage may cause a loss of sensation, making it difficult to notice injuries or developing wounds. Without proper...

Read more

Path Fertility Releases its SpermQT Facts Sheet

March 17, 2026 8:35 AM

Path FertilityTM, an epigenetics-driven fertility technology company, today unveiled its SpermQTTM Facts Sheet, a copy of which is embedded below within this news release.BEGINNING OF Path Fertility's SpermQT Facts Sheet.SpermQTIntroductionSpermQT is a clinically validated epigenetic sperm quality test from Path Fertility designed to help answer a practical question in fertility care: Are sperm likely to function well enough to support...

Read more

Aspire Biopharma's Subsidiary, Buzz Bomb Caffeine Company, Appoints John Choe as Western Sales Director

March 17, 2026 8:30 AM

Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire"), wholly owned subsidiary, Buzz Bomb Caffeine Company, has appointed 25-year industry veteran John Choe as Western Sales Director. Choe joins the leadership team with a distinguished career of scaling consumer brands and leading high-performance teams across the retail and beverage sectors.Choe joins Buzz Bomb following a successful tenure as District Manager at Yerbaé (2016-2025), where he...

Read more

TRNR Exhibits at HFA 2026 with All Four Brands and Strong Leadership Presence

March 17, 2026 8:30 AM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), owner and operator of the Wattbike, CLMBR, FORME, and Ergatta fitness brands, today announced its attendance at the 2026 Health & Fitness Association Show ("HFA 2026") at the San Diego Convention Center. The Company is attending with all four of its brands and its largest-ever senior leadership team at the event. Investors can read more about TRNR's goals and presence at the show...

Read more

A New Peer-Reviewed Report Highlights the Reality Facing Some Couples and the Information Your Infertility Doctor May Not Be Telling You

March 17, 2026 8:25 AM

According to Path Fertility™, a newly published, peer-reviewed study in the Journal of Assisted Reproduction and Genetics reports that a routine Semen Analysis can return "normal" results while still missing sperm-quality issues that may affect whether some common fertility treatments work.As a result, this reality about the "Standard of Care" Semen Analysis tests used by most fertility clinics and doctors belies the emerging data that such...

Read more

Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114

March 17, 2026 8:00 AM

Protagenic Therapeutics, Inc. (OTCQB:PTIX), a clinical-stage biopharmaceutical company developing first-in-class treatments for stress-related neuropsychiatric disorders, today announced the closing of a settlement and separation related to its prior Phytanix Bio acquisition. The transaction simplifies Protagenic's capital structure, materially reducing liabilities and sharpens the Company's operating focus on PT00114.At the common-share level,...

Read more

Avant Brands Announces Strategic Realignment of European Operations and Reclaims BLK MKT Brand Rights in Germany and Switzerland

March 17, 2026 8:00 AM

Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer of ultra-premium cannabis products, today announced that its wholly-owned subsidiary, GreenTec Holdings Ltd. ("GreenTec"), has issued a formal notice of termination for its Trademark Licensing Agreement with Adjupharm GmbH ("Adjupharm"), a subsidiary of IM Cannabis Corp. The Agreement was originally announced on May 1, 2024.The decision comes as...

Read more